Ironwood Pharmaceuticals (IRWD) reported second-quarter 2026 total revenue of $113.0 million, up from $85.2 million a year earlier. GAAP net income was $51.3 million, or $0.31 per share on both a basic and diluted basis.
The company raised its 2026 guidance, including total revenue of $460 million to $485 million and U.S. LINZESS net sales of $1.15 billion to $1.20 billion. Ironwood also said it repaid $200 million of convertible senior notes with cash on hand and began active recruiting for the confirmatory Phase 3 STARS-2 trial of apraglutide.
- Q2 2026 LINZESS U.S. net sales were $282.3 million, up 14% from Q2 2025.
- Adjusted EBITDA was $83.0 million, compared with $50.1 million a year earlier.
- Cash and cash equivalents were $79.1 million at June 30, 2026.
- Operating cash flow was $58.3 million in Q2 2026, compared with $15.1 million in Q2 2025.
$IRWD Insider Trading Activity
$IRWD insiders have traded $IRWD stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $IRWD stock by insiders over the last 6 months:
- ALEXANDER J DENNER has made 0 purchases and 2 sales selling 6,730,800 shares for an estimated $20,530,448.
- RONALD SILVER (PFO & PAO) has made 0 purchases and 3 sales selling 152,063 shares for an estimated $668,268.
- MINARDO JOHN (Chief Legal Officer) has made 0 purchases and 2 sales selling 36,492 shares for an estimated $136,176.
- MICHAEL SHETZLINE (SVP, CMO, Head-Res&Drug) has made 0 purchases and 2 sales selling 32,582 shares for an estimated $121,585.
- JULIE MCHUGH sold 21,571 shares for an estimated $80,459
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IRWD Hedge Fund Activity
We have seen 114 institutional investors add shares of $IRWD stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SARISSA CAPITAL MANAGEMENT LP removed 6,730,800 shares (-42.3%) from their portfolio in Q1 2026, for an estimated $23,625,108
- STATE STREET CORP added 3,045,722 shares (+69.0%) to their portfolio in Q1 2026, for an estimated $10,690,484
- TWO SIGMA INVESTMENTS, LP added 2,995,071 shares (+105.0%) to their portfolio in Q1 2026, for an estimated $10,512,699
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,985,181 shares (+724.5%) to their portfolio in Q1 2026, for an estimated $10,477,985
- BANK OF AMERICA CORP /DE/ removed 2,838,753 shares (-24.6%) from their portfolio in Q1 2026, for an estimated $9,964,023
- AQR CAPITAL MANAGEMENT LLC added 2,811,549 shares (+59.5%) to their portfolio in Q1 2026, for an estimated $9,868,536
- JANE STREET GROUP, LLC removed 2,197,315 shares (-77.9%) from their portfolio in Q1 2026, for an estimated $7,712,575
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
